Transient ischemic attack: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Robert Badgett
(Started diagnosis section)
imported>Robert Badgett
Line 31: Line 31:
A meta-analysis of 18 [[cohort study|cohort studies]] found the risk of stroke after 7 days varies from 0% to 13%. The lowest rates were in studies of emergency treatment by specialist stroke services.<ref name="pmid17993293">{{cite journal |author=Giles MF, Rothwell PM |title=Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis |journal=Lancet Neurol |volume=6 |issue=12 |pages=1063–72 |year=2007 |pmid=17993293 |doi=10.1016/S1474-4422(07)70274-0}}</ref>
A meta-analysis of 18 [[cohort study|cohort studies]] found the risk of stroke after 7 days varies from 0% to 13%. The lowest rates were in studies of emergency treatment by specialist stroke services.<ref name="pmid17993293">{{cite journal |author=Giles MF, Rothwell PM |title=Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis |journal=Lancet Neurol |volume=6 |issue=12 |pages=1063–72 |year=2007 |pmid=17993293 |doi=10.1016/S1474-4422(07)70274-0}}</ref>


The ABCD<sup>2</sup> score can predict likelihood of subsequent [[stroke]].<ref name="pmid17258668">{{cite journal |author=Johnston SC, Rothwell PM, Nguyen-Huynh MN, ''et al'' |title=Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack |journal=Lancet |volume=369 |issue=9558 |pages=283-92 |year=2007 |pmid=17258668 |doi=10.1016/S0140-6736(07)60150-0}}</ref><ref name="pmid15993230">{{cite journal |author=Rothwell PM, Giles MF, Flossmann E, ''et al'' |title=A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack |journal=Lancet |volume=366 |issue=9479 |pages=29-36 |year=2005 |pmid=15993230 |doi=10.1016/S0140-6736(05)66702-5}}</ref>
===Calculating estimated prognosis===
The ABCD<sup>2</sup> score is a [[clinical prediction rule]] that can predict likelihood of subsequent [[stroke]].<ref name="pmid17258668">{{cite journal |author=Johnston SC, Rothwell PM, Nguyen-Huynh MN, ''et al'' |title=Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack |journal=Lancet |volume=369 |issue=9558 |pages=283-92 |year=2007 |pmid=17258668 |doi=10.1016/S0140-6736(07)60150-0}}</ref><ref name="pmid15993230">{{cite journal |author=Rothwell PM, Giles MF, Flossmann E, ''et al'' |title=A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack |journal=Lancet |volume=366 |issue=9479 |pages=29-36 |year=2005 |pmid=15993230 |doi=10.1016/S0140-6736(05)66702-5}}</ref>


The score is calculated as:
The score is calculated as:

Revision as of 07:56, 27 December 2007

This article is a stub and thus not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

Overview (summary)

A Transient Ischemic Attack (TIA) is a brief loss of neurologic function. In a TIA, the affected brain cells were not killed, but only transiently deprived of blood supply and the signs of what seems to be a stroke, (or black-out), pass quickly and completely. A TIA is often a warning sign of an impending stroke, however, and like a true stroke, is a neurologic emergency. None the less, a TIA is not a true stroke.

Diagnosis

History and physical examination

The history and physical examination of patients with a possible TIA is difficult to interpret. Two neurologists interviewing the same patient have statistically 'substantial' but imperfect agreement about whether the patient had a TIA.[1] Disagreement may occur even when a 'standardized' patient is trained to give identical histories to each neurologist.[2]

Differential diagnosis

Other disorders that may cause similar symptoms are syncope, seizure, migraine, vestibulopathy, and conversion disorder.[3]

Treatment

Anti-platelet drugs

The most effective anti-platelet treatment is probably to combine aspirin, 25 mg twice a day with extended-release dipyridamole 200 mg twice a day according to the ESPRIT[4]

The combination of aspirin and clopidogrel should probably be avoided according to the MATCH[5] and CHARISMA[6] studies.

Invasive treatment

Carotid endarterectomy may prevent stroke in patients with more than 70% stenosis of the carotid artery.[7]

Expedited care protocol

A before and after comparison study found reduced mortality fell from 10% to 2% with the following protocol started the day the patient presents for medical care:[8]

  • "antiplatelet therapy: aspirin in patients not already on antiplatelet therapy (75 mg daily), or clopidogrel if aspirin was contraindicated" (loading dose of clopidogrel 300 mg).
    • * "In patients seen within 48 h of their event, or those seen within 7 days who were thought to be at particularly high early risk", clopidogrel (75 mg daily, to be stopped after 30 days; loading dose of clopidogrel 300 mg) was recommended in addition to aspirin."[9]
    • However, as noted above combining aspirin 25 mg twice a day with extended-release dipyridamole 200 mg twice a day might be a better choice than either aspirin alone or aspirin combined with clopidogrel.
  • simvastatin 40 mg daily
  • "blood pressure lowering unless systolic blood pressure was below 130 mm Hg on repeated measurement (either by increases in existing medication, or by commencement of perindopril 4 mg daily with or without indapamide 1·25 mg daily)"
  • anticoagulation as required
  • "Brain imaging was required before starting combination antiplatelet treatment or anticoagulation after a minor stroke"

Prognosis

A meta-analysis of 18 cohort studies found the risk of stroke after 7 days varies from 0% to 13%. The lowest rates were in studies of emergency treatment by specialist stroke services.[10]

Calculating estimated prognosis

The ABCD2 score is a clinical prediction rule that can predict likelihood of subsequent stroke.[11][12]

The score is calculated as:

  • Age ≥ 60 years = 1 point
  • Blood pressure at presentation ≥ 140/90 mm Hg = 1 point
  • Clinical features
unilateral weakness = 2 points
speech disturbance without weakness = 1 point
  • Duration of attack
≥ 60 minutes = 2 points
10–59 minutes = 1 point
  • Diabetes = 1 point

Interpretation of score, the risk for stroke:

  • Score 0-3 (low)
    • 2 day risk = 1.0%
    • 7 day risk = 1.2%
  • Score 4-5 (moderate)
    • 2 day risk = 4.1%
    • 7 day risk = 5.9%
  • Score 6–7 (high)
    • 2 day risk = 8.1%
    • 7 day risk = 11.7%

References

  1. Kraaijeveld CL, van Gijn J, Schouten HJ, Staal A (1984). "Interobserver agreement for the diagnosis of transient ischemic attacks". Stroke 15 (4): 723–5. PMID 6464066[e]
  2. Koudstaal PJ, Gerritsma JG, van Gijn J (1989). "Clinical disagreement on the diagnosis of transient ischemic attack: is the patient or the doctor to blame?". Stroke 20 (2): 300–1. PMID 2919420[e]
  3. S. Claiborne Johnston, “Transient Neurological Attack: A Useful Concept?,” JAMA 298, no. 24 (December 26, 2007), http://jama.ama-assn.org/cgi/content/full/298/24/2912 (accessed December 27, 2007).
  4. Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A (2006). "Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial". Lancet 367 (9523): 1665–73. DOI:10.1016/S0140-6736(06)68734-5. PMID 16714187. Research Blogging.
  5. Diener HC, Bogousslavsky J, Brass LM, et al (2004). "Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial". Lancet 364 (9431): 331–7. DOI:10.1016/S0140-6736(04)16721-4. PMID 15276392. Research Blogging.
  6. Bhatt DL, Fox KA, Hacke W, et al (2006). "Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events". N. Engl. J. Med. 354 (16): 1706–17. DOI:10.1056/NEJMoa060989. PMID 16531616. Research Blogging.
  7. (1991) "Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators". N. Engl. J. Med. 325 (7): 445–53. PMID 1852179[e]
  8. Rothwell PM, Giles MF, Chandratheva A, et al (2007). "Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison". Lancet 370 (9596): 1432–42. DOI:10.1016/S0140-6736(07)61448-2. PMID 17928046. Research Blogging.
  9. Markus HS, Droste DW, Kaps M, et al (2005). "Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial". Circulation 111 (17): 2233–40. DOI:10.1161/01.CIR.0000163561.90680.1C. PMID 15851601. Research Blogging.
  10. Giles MF, Rothwell PM (2007). "Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis". Lancet Neurol 6 (12): 1063–72. DOI:10.1016/S1474-4422(07)70274-0. PMID 17993293. Research Blogging.
  11. Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al (2007). "Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack". Lancet 369 (9558): 283-92. DOI:10.1016/S0140-6736(07)60150-0. PMID 17258668. Research Blogging.
  12. Rothwell PM, Giles MF, Flossmann E, et al (2005). "A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack". Lancet 366 (9479): 29-36. DOI:10.1016/S0140-6736(05)66702-5. PMID 15993230. Research Blogging.